Pubblicazioni ufficiali NFL Biosciences

Azioni

Tempo reale Euronext Paris Altri mercati azionari 17:09:02 30/04/2024			Variaz. 5gg	Var. 1 gen.
1,84 ^EUR	-2,75%		-11,75%	+27,78%

2023	NFL Biosciences annuncia il deposito di una domanda di brevetto negli Stati Uniti per la riduzione del consumo di alcol con NFL-301 e la preparazione di una domanda preliminare con la FDA	CI
2023	NFL Biosciences SA annuncia cambiamenti nella dirigenza	CI

Combined general shareholders meeting	24/04	CO
Annual results	29/03	CO
Annual results	29/03	CO
Eligibility to PEA-PME (FR)	12/01	CO
Half-year report	11/10/23	CO
1st-half-year results	05/10/23	CO
1st-half-year results	05/10/23	CO
Corporate officers' Statement : Sale	21/07/23	CO
Eligibility to PEA-PME (FR)	11/07/23	CO
Corporate officers' Statement : Sale	06/07/23	CO
Corporate officers' Statement : Sale	05/07/23	CO
Minutes of the general assembly	27/06/23	CO
Minutes of the general assembly	27/06/23	CO
Mixed general Shareholders meeting notice	22/05/23	CO
Annual Report	28/04/23	CO
Annual results	25/04/23	CO
Annual results	25/04/23	CO
Admission of new securities	31/01/23	CO
Provisional calendar	17/01/23	CO
Provisional calendar	17/01/23	CO
Monthly statement on voting rights	31/12/22	CO
Half-year report	26/10/22	CO
1st-half-year results	25/10/22	CO
1st-half-year results	25/10/22	CO
Business information	05/10/22	CO